# US 2026/0065481 A1 · Method and System for Predicting Manifestation or Progression of a Retinal Malady and Method for Training Machine Learning (ML) Models for the Same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0065481 A1
- Document ID: US20260065481A1
- Status: Published application
- Kind: A1
- Application number: 19/380,068
- Filed: 2025-11-05
- Published: 2026-03-05
- Earliest claimed: 2022-03-02
- Assignees: Aeye Health, Inc.
- Applicants: AEYE Health INC.
- Inventors: Zack DVEY-AHARON; Danny MARGALIT; Amit WOHL; Yovel ROM
- Web page: https://patentgrep.com/patent/US20260065481A1

## CPC

- A61B 3/12: for looking at the eye fundus, e.g. ophthalmoscopes (A61B3/13 takes precedence)
- G06T 7/0014: {using an image reference approach}
- A61B 3/0025: {characterised by electronic signal processing, e.g. eye models}
- A61B 3/145: {by video means}
- G06N 3/045: Combinations of networks
- G06N 3/09: Supervised learning
- G06T 7/0012: {Biomedical image inspection}
- G16H 30/40: for processing medical images, e.g. editing
- G16H 50/20: for computer-aided diagnosis, e.g. based on medical expert systems
- G16H 50/30: for calculating health indices; for individual health risk assessment
- G16H 50/70: for mining of medical data, e.g. analysing previous cases of other patients
- G06T 2207/20081: Training; Learning
- G06T 2207/30041: Eye; Retina; Ophthalmic
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- G06T: IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
- G06N: COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA

## Abstract

A method for making a prediction regarding a malady in a retina of a subject, the method including: (a) receiving at least one retinal image of the retina; (b) calculating a prediction about the retina based on the at least one retinal image of the retina using at least one specialized machine learning (ML) model, the prediction pertaining to whether the malady will develop or manifest or progress in the retina within a time-period.

## Claims

### Claim 1

A method for training machine learning (ML) models, the method comprising:
(a) providing a single pre-trained ML model;
(b) training said single pre-trained ML model on a plurality of first retinal images having a first order to produce a single trained ML model, for each of said first retinal images providing a corresponding information item relating to a first predefined type, so as to be able to predict said corresponding information item of said predefined type for new retinal images;
(c) training said single trained ML model on a plurality of second retinal images including images of healthy and pre-clinical retinas, with regards to a predefined malady, to produce a specialized ML model able to provide prediction data as to whether said new retinal images of new retinas are indicative of said predefined malady manifesting or progressing in said new retinas over a given time-period.

### Claim 2 (depends on 1)

The method of claim 1, further comprising:
providing at least one additional pre-trained ML model;
training each of said at least one additional pre-trained ML model on said plurality of first retinal images, to produce at least one addition trained ML model, wherein said first retinal images are uniquely ordered for each of said at least one additional pre-trained ML model; and
training each of said at least one additional trained ML model on said plurality of second retinal images to produce at least one additional specialized ML model.

### Claim 3 (depends on 2)

The method of claim 2, further comprising:
training each of said single specialized ML model and said at least one additional specialized ML model on at least one additional ordered arrangement of said plurality of second retinal images to produce at least one additional specialized ML model per ordered arrangement.

### Claim 4 (depends on 2)

The method of claim 2, further comprising:
training each of said single specialized ML model and said at least one additional specialized ML model on a unique pluralities of said second retinal images to produce at least one additional specialized ML model per unique plurality.

### Claim 5 (depends on 1)

The method of claim 1, further comprising:
providing at least one additional pre-trained ML model;
training each of said at least one additional pre-trained ML model on a unique plurality of said first retinal images, to produce at least one addition trained ML model, wherein said first retinal images are uniquely ordered for each of said at least one additional trained ML model.

### Claim 6 (depends on 1)

The method of claim 1, further comprising:
providing at least one additional pre-trained ML model;
training each of said at least one additional pre-trained ML model on said plurality of first retinal images and for each of said first retinal images providing a corresponding information item relating to a unique predefined type, so as to be able to predict said corresponding information item of said unique type for new retinal images.

### Claim 7 (depends on 1)

The method of claim 1, wherein said healthy images include:
(i) images of healthy retinas that will not develop a predefined malady over a given time-period,
(ii) images of healthy retinas that will develop a pre-clinical level of severity of said predefined malady over said given time-period, and
(iii) images of healthy retinas that will develop a clinical level of severity of said predefined malady over said given time-period; and
wherein said pre-clinical images include:
(iv) images of preclinical retinas with said pre-clinical level of severity of said predefined malady that will progress to said clinical level of severity of said predefined malady over said given time-period, and
(v) images of preclinical retinas with said pre-clinical level of severity of said predefined malady that will not progress to said clinical level of severity of said predefined malady over said given time-period;
wherein said model(s), after said training on said first plurality of images and said second plurality of images are able to predict whether said retina will develop over said given period of time a pre-clinical level of said predefined malady, a clinical level of said predefined malady or will not develop said predefined malady.

### Claim 8 (depends on 1)

The method of claim 1, wherein said predefined malady is Diabetic Retinopathy (DR).

### Claim 9 (depends on 1)

The method of claim 1, wherein said new retinal images include multiple images of said new retinas from different angles.

### Claim 10 (depends on 1)

The method of claim 1, wherein images in said plurality of first retinal images and said plurality of said second retinal images are stochastically ordered.

### Claim 11 (depends on 2)

The method of claim 2, wherein said healthy images include:
(i) images of healthy retinas that will not develop a predefined malady over a given time-period,
(ii) images of healthy retinas that will develop a pre-clinical level of severity of said predefined malady over said given time-period, and
(iii) images of healthy retinas that will develop a clinical level of severity of said predefined malady over said given time-period; and
wherein said pre-clinical images include:
(iv) images of preclinical retinas with said pre-clinical level of severity of said predefined malady that will progress to said clinical level of severity of said predefined malady over said given time-period, and
(v) images of preclinical retinas with said pre-clinical level of severity of said predefined malady that will not progress to said clinical level of severity of said predefined malady over said given time-period;
wherein said model(s), after said training on said first plurality of images and said second plurality of images are able to predict whether said retina will develop over said given period of time a pre-clinical level of said predefined malady, a clinical level of said predefined malady or will not develop said predefined malady.
